n,n-dideethylchloroquine has been researched along with lacidipine in 1 studies
| Studies (n,n-dideethylchloroquine) | Trials (n,n-dideethylchloroquine) | Recent Studies (post-2010) (n,n-dideethylchloroquine) | Studies (lacidipine) | Trials (lacidipine) | Recent Studies (post-2010) (lacidipine) |
|---|---|---|---|---|---|
| 23 | 0 | 1 | 357 | 111 | 71 |
| Protein | Taxonomy | n,n-dideethylchloroquine (IC50) | lacidipine (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 5.735 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.9 | |
| Adenosine receptor A3 | Homo sapiens (human) | 4.036 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 2 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 3.918 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 4.036 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 5.735 | |
| Thromboxane-A synthase | Homo sapiens (human) | 1.694 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 2 | |
| D(3) dopamine receptor | Homo sapiens (human) | 6.17 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 4.036 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
1 other study(ies) available for n,n-dideethylchloroquine and lacidipine
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |